Travere Therapeutics TVTX
NASDAQ TVTX
$59.30 -0.69 (-1.15%)
As of: Sep 30, 2026 · 11:49 AM EDT

Travere Therapeutics (TVTX) Non-Current Assets (2013 - 2026)

Updated

Travere Therapeutics' Non-Current Assets was $184.22 million in Q2 2026, up 4.8% from $175.74 million a year earlier and up 13.4% from the prior quarter.

Analysis

Travere Therapeutics (TVTX) Non-Current Assets (2013 - 2026) Analysis & Trends

At the end of FY2025, Non-Current Assets at Travere Therapeutics came in at $167.63 million, down 5.5% from FY2024.

  • Non-Current Assets shows a five-year compound annual growth rate of -3.2% (FY2020 to FY2025).
  • In earlier years, Non-Current Assets was $177.42 million in FY2024 (+3.1%), $172.14 million in FY2023 (-7.5%), $186.15 million in FY2022 (-4.0%) and $193.81 million in FY2021 (-1.6%).
  • The Q2 2026 figure marks the highest quarterly Non-Current Assets since Q2 2023.
  • Compared with a year earlier, Non-Current Assets was higher in three of the last eight quarters, with growth averaging 0.4%.
  • The best year-over-year quarter for Non-Current Assets over five years was Q3 2024 (growth of 22.5%); the worst was Q3 2023 (a decline of 23.4%).
  • Per Business Quant data, TVTX's Non-Current Assets in the three quarters before Q2 2026 was $162.51 million (Q1 2026), $167.63 million (Q4 2025) and $167.47 million (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Non-Current Assets (Qtr)
1 Johnson & Johnson 655.56 Bn 574.09 Bn 17.26 Bn 141.29 Bn
2 AbbVie 470.94 Bn 444.10 Bn 12.70 Bn 101.45 Bn
3 Merck 367.14 Bn 321.57 Bn 12.21 Bn 125.00 Mn
4 Novartis Ag 280.33 Bn 236.20 Bn 11.24 Bn 94.68 Bn
5 Astrazeneca 257.78 Bn 231.34 Bn 12.86 Bn 87.87 Bn
6 Amgen 226.04 Bn 181.44 Bn 7.24 Bn 60.68 Bn
7 Gilead Sciences 188.89 Bn 163.01 Bn 6.22 Bn 35.42 Bn
8 Pfizer 163.75 Bn 110.70 Bn 10.94 Bn 159.77 Bn
9 Vertex Pharmaceuticals 133.68 Bn 105.69 Bn 2.84 Bn 14.88 Bn
10 Travere Therapeutics 5.80 Bn 5.40 Bn 167.41 Mn 184.22 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 184.22 Mn
Mar 31, 2026 162.51 Mn
Dec 31, 2025 167.63 Mn
Sep 30, 2025 167.47 Mn
Jun 30, 2025 175.74 Mn
Mar 31, 2025 174.63 Mn
Dec 31, 2024 177.42 Mn
Sep 30, 2024 179.67 Mn
Jun 30, 2024 182.14 Mn
Mar 31, 2024 182.47 Mn
Dec 31, 2023 172.14 Mn
Sep 30, 2023 146.62 Mn
Jun 30, 2023 194.37 Mn
Mar 31, 2023 203.33 Mn
Dec 31, 2022 186.15 Mn
Sep 30, 2022 191.37 Mn
Jun 30, 2022 192.72 Mn
Mar 31, 2022 197.31 Mn
Dec 31, 2021 193.81 Mn
Sep 30, 2021 196.00 Mn
API Access

Travere Therapeutics Non-Current Assets API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=non-current-assets&ticker=TVTX&period=max&api_key=YOUR_API_KEY